What is the FII and DII shareholding of Concord Biotech?

Foreign Institutional Investors (FIIs) own 7.28%. Domestic Institutional Investors (DIIs) hold 5.11% of Concord Biotech.

What is the retail shareholding of Concord Biotech?

The retail shareholding of Concord Biotech is 37.68%

The shareholding pattern of Concord Biotech is updated quarterly as per SEBI regulations.

CONCORDBIO|543960|Pharmaceuticals

₹1,163.50₹1,163.50-₹82.10 (-6.59%)

As on 02 Nov, 2026 | 15:59 IST

Shareholding Pattern

Promoters (44.09%)	Mutual funds (5.84%)	Retail and other (37.68%)
FII (7.28%)	Other DII (5.11%)

Promoters

Category	Sep 2026	Jun 2026	Mar 2026	Dec 2025
Promoters	44.09%	44.08%	44.08%	44.08%
FII	7.28%	7.52%	7.80%	7.58%
Other DII	5.11%	4.96%	4.92%	5.15%
Retail and other	37.68%	39.03%	38.90%	38.76%
Mutual funds	5.84%	4.40%	4.30%	4.44%

The promoters of Concord Biotech currently hold 44.09% of the company’s total shares.